Resumen de acción MD
Pediatrix Medical Group, Inc. junto con sus filiales, presta servicios de atención neonatal, materno-fetal, cardiología pediátrica y otras subespecialidades pediátricas en Estados Unidos.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Competidores de Pediatrix Medical Group, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.24 |
| 52 Week High | US$15.06 |
| 52 Week Low | US$7.70 |
| Beta | 1.58 |
| 1 Month Change | -0.43% |
| 3 Month Change | -6.85% |
| 1 Year Change | -34.23% |
| 3 Year Change | -64.89% |
| 5 Year Change | -67.30% |
| Change since IPO | 72.91% |
Noticias y actualizaciones recientes
Recent updates
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29
Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Is MEDNAX (NYSE:MD) A Risky Investment?
Jul 19MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital
Jun 27Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are
May 15Mednax Q1 2021 Earnings Preview
May 06Does MEDNAX (NYSE:MD) Have A Healthy Balance Sheet?
Mar 14Returns On Capital At MEDNAX (NYSE:MD) Paint An Interesting Picture
Feb 15
Rentabilidad de los accionistas
| MD | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 4.9% | 2.1% | 1.2% |
| 1Y | -34.2% | 3.6% | 24.7% |
Rentabilidad vs. Industria: MD obtuvo unos resultados inferiores a los del sector US Healthcare , que el año pasado arrojó un rendimiento del 4%.
Rentabilidad vs. Mercado: MD obtuvo unos resultados inferiores a los del mercado US, que fue del 19.3% el año pasado.
Volatilidad de los precios
| MD volatility | |
|---|---|
| MD Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: MD no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de MD (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1979 | 5,450 | Jim Swift | www.pediatrix.com |
Pediatrix Medical Group, Inc. junto con sus filiales, presta servicios de atención neonatal, materno-fetal, cardiología pediátrica y otras subespecialidades pediátricas en Estados Unidos. Ofrece servicios de atención neonatal, como atención clínica a bebés nacidos prematuramente o con complicaciones dentro de unidades específicas en hospitales a través de médicos subespecialistas en neonatología, enfermeras especializadas en neonatología y otros clínicos pediátricos. La empresa también presta servicios de atención maternofetal, como atención clínica hospitalaria y en consulta a mujeres embarazadas y fetos a través de subespecialistas en medicina maternofetal afiliados, así como obstetras y otros médicos, como enfermeros especializados en atención maternofetal, enfermeras matronas certificadas, ecografistas y asesores genéticos.
Resumen de fundamentos de Pediatrix Medical Group, Inc.
| Estadísticas fundamentales de MD | |
|---|---|
| Capitalización bursátil | US$777.09m |
| Beneficios(TTM) | -US$60.41m |
| Ingresos (TTM) | US$1.99b |
0.4x
Ratio precio-ventas (PS)-12.6x
Ratio precio-beneficio (PE)¿Está MD sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de MD | |
|---|---|
| Ingresos | US$1.99b |
| Coste de los ingresos | US$1.57b |
| Beneficio bruto | US$421.57m |
| Otros gastos | US$481.97m |
| Beneficios | -US$60.41m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 07, 2024
| Beneficios por acción (BPA) | -0.73 |
| Margen bruto | 21.13% |
| Margen de beneficio neto | -3.03% |
| Ratio deuda/patrimonio | 73.5% |
¿Cómo se ha desempeñado MD a largo plazo?
Ver rendimiento histórico y comparativa